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CORRESPONDENCE
Aseptic meningitis as a delayed neurologic
complication of murine typhus
Murine typhus (MT) is a zoonotic infection of
worldwide distribution, caused by Rickettsia typhi,
which is transmitted to humans by the bite of
the rat ﬂea. In the southwest of Spain, MT is an
established and prevalent cause of fever of inter-
mediate duration [1–3]. The clinical course is usu-
ally benign, with systemic manifestations such as
fever, arthromyalgia and headache predominat-
ing. Rash, which appears in our area in 62.5% of
cases, is in most cases mild and non-conﬂuent, but
its detection may be an important clue to the diag-
nosis [2]. Neurologic complications are considered
rare and include meningitis and/or encephalitis,
with focal neurologic signs such as confusion,
stupor, seizures and ataxia [4].
We report the case of a patient with MT who
developed an aseptic meningitis with diplopia,
despite receiving early treatment with doxycycline.
A 50-year-old male was admitted to the hospital
after suffering fever, generalized arthromyalgia,
asthenia and diffuse abdominal pain for one week.
His past medical historywas not relevant. He lived
in an urban area, and had frequent contact with
cats and dogs, but did not remember any insect
bite in recent days. Physical examination revealed
a good general health status, despite the presence
of fever (39 8C), a mild maculopapular rash with-
out involvement of palms and soles and hepato-
megaly of 3 cm. Neurologic examination revealed
no abnormality. Laboratory tests disclosed slight
leukopenia, and thrombocytopenia (42 000 plate-
lets/mm3), without anemia, increased levels of
serum aspartate aminotransferase (331UI/L),
alanine aminotransferase (227UI/L), gammaglu-
tamyl transpeptidase (526UI/L), and alkaline
phosphatase (609UI/L). Coagulation parameters
and renal function were normal. Chest X-ray and
abdominal ultrasonography showed no abnorm-
alities. Serologic studies for the detection of anti-
bodies against Coxiella burnetii, Leptospira spp.,
Borrelia spp., cytomegalovirus, Epstein–Barr virus
and B and C hepatitis virus revealed non-diagnos-
tic titers. Immunoﬂuorescence antibody assay
(IFA) against R. typhi showed a titer of IgG anti-
bodies of 1/512. Treatment with doxycycline was
started, andmaintained for twoweeks. The patient
recovered well, with disappearance of fever and
rash in 14 days, and analytical parameters return-
ing to normal values; he was discharged on day 21
after the start of fever. A week later he was read-
mitted because of asthenia, headache and diplopia.
He remained in good general health. Neurologic
examination, including fundoscopy, was normal.
The rest of the physical examination revealed no
abnormality, with the exception of mild fever
(37.4 8C). A cranial computerized tomography
scan showed no alterations. Analysis of cerebrosp-
inal ﬂuid (CSF) showed mild lymphocytic pleo-
cytosis (86 cells/mm3, 75% lymphocytes), 1 g/L of
proteins, and normal glucose levels. CSF stains,
including Zielh-Nielsen staining, and aerobic and
anaerobic and Lo¨wenstein–Jensen cultures were
negative. CSF serologic studies for the detection of
antibodies against C. burnetii, Leptospira spp. and
Borrelia spp. were also negative. On day 30, a
second serum IFA for the detection of IgG anti-
bodies against R. typhi showed a titer of 1/16 384.
Ciproﬂoxacin was then prescribed (750mg twice-
daily) for two weeks. The patient improved within
24 h of initiating this treatment, and ﬁnally recov-
ered uneventfully, being discharged on day 15
after the second admission.
This patient developed aseptic meningitis as a
delayed neurologic manifestation of MT. Several
features of the case are remarkable. The ﬁrst is the
infrequent occurence of this complication. Reports
of MT cases with neurologic manifestations are
rare [5,6]. Focal neurologic symptoms are even
more uncommon, with papilledema and, subse-
quently, visual alterations the predominant mani-
festations when they do appear [6]. Memory
impairment and behavioral alterations have also
been described [7]. Nevertheless, clinicians should
always take MT into account, and include it in the
differential diagnosis of any patient with subacute
meningitis in endemic areas [6], especially as in
this case when other suggestive features such as
rash are present. The second remarkable feature is
the absence of comorbidities in the patient that
could predispose him to the development of any
complication. Most reported cases with a severe
coursewere senile patientswith predisposing com-
orbidities [8]; among these, the most frequent were
renal failure, jaundice, and sulfonamide use [8].
Nevertheless, predisposing factors for the devel-
opment of neurologic manifestations have not
been reported. Finally, there is the appearance of
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this complication in spite of correct treatment
with doxycycline, and the ﬁnal resolution with a
course of ciproﬂoxacin. Doxycycline is the drug of
choice for the treatment of MT, and, what is more,
an early start of correct therapy for MT is asso-
ciated with an earlier defervescence of fever, lower
complication rates, and lower mortality [2]. On the
other hand, quinolones are considered drugs of
second choice, and constitute an alternative in
cases of doxycycline-resistance [9]. In the report
case, however, ﬁnal resolution of the disease was
achieved with the use of ciproﬂoxacin. To explain
the failure of initial doxycycline treatment, we
hypothesize that the strain may have been res-
istant to doxycycline, that doxycycline is bacte-
riostatic, in contrast to ciproﬂoxacin, and that
doxycycline penetrates the central nervous system
to a lesser extent.
In conclusion, we report the case of a patient
who developed aseptic meningitis as a delayed
complication of MT in spite of having been cor-
rectly treated with doxycycline. In endemic areas,
MT should be suspected in any patient with asep-
tic meningitis, especially when other suggestive
features such as rash are present.
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